Sentences with phrase «human genomics research»

The first government - funded human genomics research study performed on African soil — aimed at unlocking the unique genetic character of southern African populations — has revealed a high level of genetic diversity.
In a 2016 National Institutes of Health summer internship at the National Human Genomic Research Institute, Sappington conducted a third research project in which she demonstrated a fast, alignment - free computational method for identifying orthologs — similar genes from species that are related by descent from a common ancestor.
In this session, we will discuss methods for integrated analysis of DNA and RNA and their application in human genomic research in the areas of cancer genomics, human disease research, and regulation of gene expression.

Not exact matches

His institute is a leading research organization dedicated to genomic research, and he's the co-founder, chairman and CEO of Human Longevity.
His institute is a leading organization dedicated to genomic research, and he's the co-founder, executive chairman and CEO of Human Longevity.
Last June, he switched to the Department of Human DNA Variability at the Centre for Genomic and Oncological Research in Granada.
Even though Rienhoff is the founder of two biotechnology companies and holds a medical degree from Johns Hopkins University, he has conducted his hunt not as an expert in human genomics but as a do - it - yourself biologist, teaching himself the tricks of the trade as he moves along and doing his research at home.
«They are developing the clinical genomics necessary to foster and support the Precision Medicine Initiative of the National Institutes of Health, and generating the genomics data that further drives human genome research
Using genomic analysis to study cancer in dogs can help develop new therapies for humans with cancer, according to a proof - of - concept study led by the National Cancer Institute (NCI) and the Translational Genomics Research Institute (TGen).
The move comes in response to the announcement earlier this week of a new U.S. company, launched by sequencing - machine manufacturer Perkin - Elmer and J. Craig Venter of The Institute for Genomic Research, that plans a brute - force approach to sequencing the human genome within 3 years (ScienceNOW, 12 May).
«Right now, the research group is analyzing the nuclear genome the results of which could provide us with information about its relationship with the Neanderthals and about the existence of genomic variations associated with the immune system that accounts for the evolutionary success of Homo sapiens over other human species with whom it co-existed.
The institute, called the Institute for Genomic Research, is funded by a ten - year, $ 70 million grant from Human Genome Sciences, a private company set up by venture capitalists.
The U.S. National Human Genome Research Institute and the National Academy of Medicine recently brought together 25 of these groups to compare projects, to examine the current state of implementation and desired near - term capabilities, and to identify opportunities for collaboration that promote the responsible practice of genomic medicine.
Indeed, according to a report last year by the research and management organization Battelle, «In 2010 alone, the human genome sequencing projects and associated genomics research and industry activity directly and indirectly generated $ 67 billion in U.S. economic output and supported 310,000 jobs that produced $ 20 billion in personal income.»
That is why a second group of scientists — including J. Craig Venter, the entrepreneur and biologist whose Institute for Genomic Research in Rockville, Md., played a key role in mapping the human genome — argues for a bolder approach.
During the last several years, research efforts with human cell lines revealed that the genomic loci encoding tRNAs give rise to shorter tRNA fragments («tRFs»).
But John Quackenbush of The Institute for Genomic Research (TIGR) in Rockville, Maryland, put his dollar on 118,259 genes, an estimate based on the genes in TIGR's human gene index, while a 153,478 - genes entry came in from Sam LaBrie of Incyte Genomics, a California - based company that in September 1999 announced that the human genome had at least 140,000 genes.
I see firsthand how their efforts help people understand and appreciate genomics research and its impact on human health.»
The Obama Administration is exploring fundamental reforms to human subjects protections — actions that are being driven in part by the fact that technological advances, especially in genomics and computing, have made the notion of «de-identifying» a research participant's biological sample virtually impossible.
The hostilities involve institutions (M.I.T. and Harvard versus University of California), gender (Doudna, Charpentier, Zhang), geography (east versus west coast) and what you might call über - institutions (the Broad Institute, which has become an empire of genomic research under Lander's direction, especially after his leading role in the Human Genome Project, versus the Howard Hughes Medical Institute, whose president, Robert Tjian, is based at Berkeley and has co-authored at least one CRISPR paper with Doudna, also an HHMI investigator).
Coleman added that further research is needed to determine whether cell fusion events between normal human cell types result in genomic catastrophe and neoplastic transformation.
In 2003, in «A vision for the future of genomics research,» Francis Collins — who was then the director of the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health — and his co-authors encouraged collaboration between basic scientists and clinical scientists, and between life scientists and social scientists, to address the ethical, legal, and social implications of genomic and genetic research and the resulting new technresearch,» Francis Collins — who was then the director of the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health — and his co-authors encouraged collaboration between basic scientists and clinical scientists, and between life scientists and social scientists, to address the ethical, legal, and social implications of genomic and genetic research and the resulting new technResearch Institute (NHGRI), part of the National Institutes of Health — and his co-authors encouraged collaboration between basic scientists and clinical scientists, and between life scientists and social scientists, to address the ethical, legal, and social implications of genomic and genetic research and the resulting new technresearch and the resulting new technologies.
Led by scientists at The Institute for Genomic Research (TIGR) in Rockville, Maryland, and the Wellcome Trust Sanger Institute in the United Kingdom, the study indicates that the amoeba has snagged an astonishing 92 genes from bacteria in recent times, presumably by gobbling them up during its life in the human gut.
The study analyzed data from The Cancer Genome Atlas (TCGA), a research program supported by the National Cancer Institute and National Human Genome Research Institute within the National Institutes of Health that is looking at genomic changes in more than 20 different types ofresearch program supported by the National Cancer Institute and National Human Genome Research Institute within the National Institutes of Health that is looking at genomic changes in more than 20 different types ofResearch Institute within the National Institutes of Health that is looking at genomic changes in more than 20 different types of cancer.
A collaboration of premier academic, medical and industry leaders across the globe, the New York Genome Center has as its goal to translate genomic research into the development of new treatments, therapies and therapeutics against human disease.
«The availability of the human genome sequence, as well as other genomic resources produced by our sequencing centers, has transformed biomedical research everywhere,» said NHGRI's Associate Director of Extramural Research Jane Peterson, Ph.D., who is also a program director for NHGRI's Large - Scale Sequencing Research research everywhere,» said NHGRI's Associate Director of Extramural Research Jane Peterson, Ph.D., who is also a program director for NHGRI's Large - Scale Sequencing Research Research Jane Peterson, Ph.D., who is also a program director for NHGRI's Large - Scale Sequencing Research Research Network.
The code does not place unrealistic demands on scientists, says Himla Soodyall, director of the Human Genomic Diversity and Disease Research Unit at South Africa's University of the Witwatersrand in Johannesburg.
Robert Wildin, M.D., a clinical geneticist with nearly three decades of experience in private and hospital - based medical practice, joined the National Human Genome Research Institute (NHGRI) on Nov. 10, 2014 as chief of the Genomic Healthcare Branch (GHB).
The branch also serves as an informational resource and liaison for parties interested in policy matters related to human genetics and genomics research.
The INFRAFRONTIER mission: ◊ to shape the European Research Area in the field of mouse functional genomics and thereby make an important contribution to the study of human disease.
The debate about genomic editing of human embryos is unlikely to follow the recommendations for systematic forethought proposed by illustrious research bodies and reports.
Research interests: primate comparative genomics, adaptive evolution, human brain evolution, infectious diseases in primate hosts, HIV / SIV and AIDS, evolutionary medicine, colobines
The advent of accessible and relatively inexpensive high - throughput sequencing technology has resulted in extensive sequencing of whole human genomes or exomes in a research setting and seems likely to lead to an explosion of genomic sequencing in a clinical context.
He recently moved back to academia as an associate professor in the departments of Neuroscience and Human Genetics & Genomic Sciences at the Icahn School of Medicine at Mount Sinai in New York, where he continues his basic research and translational efforts in AD using a state - of - the - art experimental and computational toolkit, in collaboration with Drs. Alison Goate and Anne Schaefer within the Ronald M. Loeb Center for Alzheimer's Disease.
Founded by J. Craig Venter, Ph.D., the JCVI is home to approximately 300 scientists and staff with expertise in human and evolutionary biology, genetics, bioinformatics / informatics, information technology, high - throughput DNA sequencing, genomic and environmental policy research, and public education in science.
Participating institutions: Helmholtz Association • CNRS • Institute of Molecular Biotechnology • Research Center for Molecular Medicine of the Austrian Academy of Sciences • VIB - KU Leuven • Friedrich Miescher Institute for Biomedical Research • University of Basel • University of Zurich • Central European Institute of Technology • Max Planck Institute of Immunobiology and Epigenetics • Max Planck Institute for Molecular Genetics • German Cancer Research Center • Max Delbrück Center for Molecular Medicine • German Center for Neurodegenerative Diseases • Helmholtz Zentrum München • Max Planck Institute for Evolutionary Anthropology • Helmholtz Institute of RNA - based Infection Research • Saarland University • Technical University Munich • University of Würzburg • Biotech Research & Innovation Centre • Interdisciplinary Nanoscience Center • University of Copenhagen • Centre for Genomic Regulation • Institut Curie • Université de Montpellier • Inserm • Université Toulouse III — Paul Sabatier • École nationale supérieure des mines de Paris • Institute for Molecular Medicine Finland • The Biomedical Research Foundation, Academy of Athens • Weizmann Institute of Science • Hebrew University • Sapienza — University of Rome • Instituto Nazionale Genetica Molecolare • University of Napoli • University of Padua • University of Milan • European Institute of Oncology • Netherlands Cancer Institute • Radboud University • University Medical Center Utrecht • Hubrecht Institute • Instituto Gulbenkian de Ciência • Institute of Bioorganic Chemistry of the Polish Academy of Sciences • Romanian Center for Systems Immunology • Karolinska Institute • MRC Human Genetics Unit • University of Edinburgh • Wellcome Sanger Institute • The Babraham Institute • European Molecular Biology Laboratory — European Bioinformatics Institute
Joshua leads the Human Genetics Informatics team, who are responsible for handling the informatics needs of the Human Genetics research programme, including processing of large - scale genetics and genomics data sets.
Dr. Torkamani's research covers a broad range of areas centered on the use of genomic technologies to identify the genetic etiology and underlying mechanisms of human disease in order to define precision therapies for diseased individuals.
Working with collaborators in more than 20 countries, primarily through MalariaGEN, Dominic's research focuses on investigating the biological and clinical consequences of genomic variation in human, Plasmodium and Anopheles populations.
Teri Manolio, Director, Division of Genomic Medicine, National Human Genome Research Institute, USA
Liu's scientific research focuses on the functional genomics of human cancers, particularly breast cancer, uncovering new oncogenes, and deciphering on a genomic scale the dynamics of gene regulation that modulate cancer biology.
Moderator: Teri Manolio, Director, Division of Genomic Medicine, National Human Genome Research Institute (USA)
She has made an important contribution to several international research consortia in human genomics, including the Genotype Tissue Expression (GTEx) Project, the 1000 Genomes Project and led the RNA - sequencing work of the Geuvadis Consortium.
BETHESDA, Md., Thurs., Oct. 14, 2004 - The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), today announced it has awarded more than $ 38 million in grants to spur the development of innovative technologies designed to dramatically reduce the cost of DNA sequencing, a move aimed at broadening the applications of genomic information in medical research and healResearch Institute (NHGRI), part of the National Institutes of Health (NIH), today announced it has awarded more than $ 38 million in grants to spur the development of innovative technologies designed to dramatically reduce the cost of DNA sequencing, a move aimed at broadening the applications of genomic information in medical research and healresearch and health care.
The Genomic Medicine Institute (GMI) and the Center for Clinical Genomics are excited to announce a broad research collaboration with Human Longevity Inc., (HLI), Dr. J. Craig Venter's company in San Diego, CA.
Interface of Genomics Research and Genomic Medicine Recent advances in DNA sequencing technologies mean that it is now possible to conduct genomic analyses, including analysis of the entire genome of an individual human, that just a few years ago would have been too costly anGenomic Medicine Recent advances in DNA sequencing technologies mean that it is now possible to conduct genomic analyses, including analysis of the entire genome of an individual human, that just a few years ago would have been too costly angenomic analyses, including analysis of the entire genome of an individual human, that just a few years ago would have been too costly and slow.
The JCVI teams are focused on a variety of genomic research areas including continued work in synthetic biology; sampling and analysis of the world's oceans, fresh water and soils to better understand the microbes living in these environments; and new analysis on the human genome in the hopes of discovering new insights into disease prevention and treatment.
Ageing research and more generally the study of the functional basis of human diseases profit enormously from the large - scale approaches and resources in mouse functional genomics: systematic targeted mutation of the mouse genome, systemic phenotyping in mouse clinics, and the archiving and distribution of the mouse resources in public repositories.
Diversity in Genomics Research Cohorts The lack of diversity within participant cohorts in genetics and genomics research limits our ability to study variation across the human genome and the genetic factors that influence health and disease, as well as our ability to ensure that every segment of the population is able to benefit from advances stemming from the rResearch Cohorts The lack of diversity within participant cohorts in genetics and genomics research limits our ability to study variation across the human genome and the genetic factors that influence health and disease, as well as our ability to ensure that every segment of the population is able to benefit from advances stemming from the rresearch limits our ability to study variation across the human genome and the genetic factors that influence health and disease, as well as our ability to ensure that every segment of the population is able to benefit from advances stemming from the researchresearch.
«Martin Pera brings an unparalleled depth of expertise in embryonic and pluripotent stem cell biology to our faculty, complementing and broadening our emerging research emphasis on human genomic medicine,» said Edison Liu, M.D., president and CEO of The Jackson Laboratory.
a b c d e f g h i j k l m n o p q r s t u v w x y z